Aravive Inc (USD)
ARAV
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range11.06 | 11.92
52-Wk Range3.07 | 15.62
Last Close11.99
Mkt Cap (m)179.25
Dividend yield-
ISINUS03890D1081
Volume200,488
Exchange VenueNAS

Company Profile

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Key Information
Price/Earning-
Price/Book3.77
Price/Sales21.80
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -2705.98
Net Margin %-5567.69
Return on Equity-106.98
Debt/Equity0.12

Legal Documents

Prospectus
en 27/11/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)-401
Operating Income (m)-19-46-83-96-84-37
Net Income (m)-18-58-82-96-85-76
Basic EPS-11.94-26.34-17.04-18.66-14.46-10.64
Avg. Diluted Shares Outstanding (m)235567
Balance Sheet
USD201320142015201620172018
Current Assets (m)141731852058258
Non Current Assets (m)111211
Total Assets (m)151741852069469
Current Liabilities (m)4795562
Total Liabilities (m)------
Total Equity (m)111671771518360
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-17-40-69-41-116-29
Capital Expenditure (m)-1--4-2
Figures are quoted in USD unless stated otherwise
-0.67 (-5.59%)
$
11.32
Last Price